Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 608

1.

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma.

Usmani SZ, Zhang Q, Stratton K, Qu P, Yaccoby S, Hansen E, Steward D, Panozzo S, Petty N, Hoering A, Waheed S, Van Rhee F, Crowley J, Barlogie B.

Leukemia. 2014 Aug 25. doi: 10.1038/leu.2014.248. [Epub ahead of print] No abstract available.

PMID:
25151956
[PubMed - as supplied by publisher]
2.

Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells.

Bam R, Venkateshaiah SU, Khan S, Ling W, Randal SS, Li X, Zhang Q, van Rhee F, Barlogie B, Epstein J, Yaccoby S.

Blood Cancer J. 2014 Aug 1;4:e234. doi: 10.1038/bcj.2014.54.

PMID:
25083818
[PubMed - in process]
3.

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.

Heuck CJ, Qu P, van Rhee F, Waheed S, Usmani SZ, Epstein J, Zhang Q, Edmondson R, Hoering A, Crowley J, Barlogie B.

Leukemia. 2014 Jul 31. doi: 10.1038/leu.2014.232. [Epub ahead of print] No abstract available.

PMID:
25079174
[PubMed - as supplied by publisher]
4.

CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.

Johnson SK, Stewart JP, Bam R, Qu P, Barlogie B, van Rhee F, Shaughnessy JD Jr, Epstein J, Yaccoby S.

Blood. 2014 Sep 25;124(13):2051-60. doi: 10.1182/blood-2014-02-555813. Epub 2014 Jul 24.

PMID:
25061178
[PubMed - in process]
5.

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.

Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, GarcĂ­a-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, Leblond V, Advani RH, Gertz MA, Kyriakou C, Thomas SK, Barlogie B, Gregory SA, Kimby E, Merlini G, Treon SP.

Blood. 2014 Aug 28;124(9):1404-1411. Epub 2014 Jul 15. Review.

PMID:
25027391
[PubMed - as supplied by publisher]
Free PMC Article
6.

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis.

Papanikolaou X, Johnson S, Garg T, Tian E, Tytarenko R, Zhang Q, Stein C, Barlogie B, Epstein J, Heuck C.

Oncotarget. 2014 Jun 30;5(12):4118-28.

PMID:
24948357
[PubMed - in process]
Free PMC Article
7.

Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance.

Yang JD, Girotra M, Restrepo A, Waheed S, Barlogie B, Duarte-Rojo A.

Ann Hepatol. 2014 Jul-Aug;13(4):461-5.

PMID:
24927619
[PubMed - in process]
8.

A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.

Srkalovic G, Hussein MA, Hoering A, Zonder JA, Popplewell LL, Trivedi H, Mazzoni S, Sexton R, Orlowski RZ, Barlogie B.

Cancer Med. 2014 Jun 10. doi: 10.1002/cam4.276. [Epub ahead of print]

PMID:
24913924
[PubMed - as supplied by publisher]
9.

The future of autologous stem cell transplantation in myeloma.

van Rhee F, Giralt S, Barlogie B.

Blood. 2014 Jul 17;124(3):328-33. doi: 10.1182/blood-2014-03-561985. Epub 2014 Jun 3.

PMID:
24894774
[PubMed - in process]
10.

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use.

van Laar R, Flinchum R, Brown N, Ramsey J, Riccitelli S, Heuck C, Barlogie B, Shaughnessy JD Jr.

BMC Med Genomics. 2014 May 17;7:25. doi: 10.1186/1755-8794-7-25.

PMID:
24885236
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Muscular Relapse in a Patient With Multiple Myeloma.

Waheed S, Zhu H, Waheed MA, Kumar M, Barlogie B.

J Clin Oncol. 2014 Apr 28. [Epub ahead of print] No abstract available.

PMID:
24778395
[PubMed - as supplied by publisher]
12.

Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma.

Guru Murthy GS, Sawyer J, Alapat D, Samant R, Barlogie B.

Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):e127-9. doi: 10.1016/j.clml.2014.02.008. Epub 2014 Feb 28. No abstract available.

PMID:
24685577
[PubMed - in process]
13.

In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.

Tian E, Sawyer JR, Heuck CJ, Zhang Q, van Rhee F, Barlogie B, Epstein J.

Genes Chromosomes Cancer. 2014 Jul;53(7):549-57. doi: 10.1002/gcc.22165. Epub 2014 Mar 17.

PMID:
24638926
[PubMed - in process]
14.

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data.

Palumbo A, Bringhen S, Kumar SK, Lupparelli G, Usmani S, Waage A, Larocca A, van der Holt B, Musto P, Offidani M, Petrucci MT, Evangelista A, Zweegman S, Nooka AK, Spencer A, Dimopoulos MA, Hajek R, Cavo M, Richardson P, Lonial S, Ciccone G, Boccadoro M, Anderson K, Barlogie B, Sonneveld P, McCarthy PL.

Lancet Oncol. 2014 Mar;15(3):333-42. doi: 10.1016/S1470-2045(13)70609-0. Epub 2014 Feb 11.

PMID:
24525202
[PubMed - indexed for MEDLINE]
15.

A compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosis.

Liu YC, Reddi HV, Waheed S, Alapat D, Highsmith WE, Edmondson RD, Barlogie B, van Rhee F.

Amyloid. 2014 Jun;21(2):134-5. doi: 10.3109/13506129.2014.883373. Epub 2014 Feb 11. No abstract available.

PMID:
24517438
[PubMed - in process]
16.

Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.

Sawyer JR, Tian E, Heuck CJ, Epstein J, Johann DJ, Swanson CM, Lukacs JL, Johnson M, Binz R, Boast A, Sammartino G, Usmani S, Zangari M, Waheed S, van Rhee F, Barlogie B.

Blood. 2014 Apr 17;123(16):2504-12. doi: 10.1182/blood-2013-12-546077. Epub 2014 Feb 4.

PMID:
24497533
[PubMed - indexed for MEDLINE]
17.

Serial exome analysis of disease progression in premalignant gammopathies.

Zhao S, Choi M, Heuck C, Mane S, Barlogie B, Lifton RP, Dhodapkar MV.

Leukemia. 2014 Jul;28(7):1548-52. doi: 10.1038/leu.2014.59. Epub 2014 Feb 5. No abstract available.

PMID:
24496302
[PubMed - indexed for MEDLINE]
18.

Can autologous bone marrow transplantation improve systolic function in patients with multiple myeloma related cardiac amyloidosis?

Raina S, Pant S, Vallurupalli S, Jambhekar K, Pandey T, Grazziutti M, Barlogie B, Dai Y, Deshmukh A, Mehta JL.

Int J Cardiol. 2014 Mar 1;172(1):265-6. doi: 10.1016/j.ijcard.2013.12.249. Epub 2014 Jan 10. No abstract available.

PMID:
24456883
[PubMed - in process]
19.

Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.

Abdallah AO, Atrash S, Shahid Z, Jameel M, Grazziutti M, Apewokin S, Kumar NS, Restrepo A, Waheed S, Van Rhee F, Heuck CJ, Johann D Jr, Barlogie B, Usmani SZ.

Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):211-4. doi: 10.1016/j.clml.2013.11.004. Epub 2013 Nov 16.

PMID:
24373936
[PubMed - in process]
20.

Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables.

Abuabdou A, Rosenbaum ER, Usmani SZ, Barlogie B, Cottler-Fox M.

J Clin Apher. 2013 Dec 18. doi: 10.1002/jca.21313. [Epub ahead of print]

PMID:
24347510
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk